NCT00362141View on ClinicalTrials.gov

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

April 30, 2008

Conditions
Status Epilepticus
Interventions
DRUG

levetiracetam (add-on)

Trial Locations (1)

2512VA

RECRUITING

Medical Centre Haaglanden, The Hague

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Medical Center Haaglanden

OTHER

NCT00362141 - Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus | Biotech Hunter | Biotech Hunter